Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities

Joost Boeckmans; Alexandra Gatzios; Jörn M Schattenberg; Robim Rodrigues; Vera Rogiers; Tamara Vanhaecke

doi:10.1007/s00204-023-03498-0

Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities

Joost Boeckmans, Alexandra Gatzios, Jörn M Schattenberg, Robim Rodrigues, Vera Rogiers, Tamara Vanhaecke

Research output: Contribution to journal › Editorial

6 Downloads (Pure)

Original language	English
Pages (from-to)	1825-1827
Number of pages	3
Journal	Archives of Toxicology
Volume	97
Issue number	6
DOIs	https://doi.org/10.1007/s00204-023-03498-0
Publication status	Published - Jun 2023

Bibliographical note

Copyright:
Copyright 2023 Elsevier B.V., All rights reserved.

Keywords

NASH
genetics
pharmacogenetics
drug development
liver
hepatology

Access to Document

10.1007/s00204-023-03498-0Licence: CC BY

Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunitiesFinal published version, 484 KBLicence: CC BY

https://link.springer.com/article/10.1007/s00204-023-03498-0Licence: CC BY

Cite this

@article{cd30b9dff0c04f14966a8ca296e276c3,

title = "Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities",

keywords = "NASH, genetics, pharmacogenetics, drug development, liver, hepatology",

author = "Joost Boeckmans and Alexandra Gatzios and Schattenberg, {J{\"o}rn M} and Robim Rodrigues and Vera Rogiers and Tamara Vanhaecke",

year = "2023",

month = jun,

doi = "10.1007/s00204-023-03498-0",

language = "English",

volume = "97",

pages = "1825--1827",

journal = "Archives of Toxicology",

issn = "0340-5761",

publisher = "Springer Verlag",

number = "6",

}

TY - JOUR

T1 - Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities

AU - Boeckmans, Joost

AU - Gatzios, Alexandra

AU - Schattenberg, Jörn M

AU - Rodrigues, Robim

AU - Rogiers, Vera

AU - Vanhaecke, Tamara

PY - 2023/6

Y1 - 2023/6

KW - NASH

KW - genetics

KW - pharmacogenetics

KW - drug development

KW - liver

KW - hepatology

UR - http://www.scopus.com/inward/record.url?scp=85158170422&partnerID=8YFLogxK

U2 - 10.1007/s00204-023-03498-0

DO - 10.1007/s00204-023-03498-0

M3 - Editorial

VL - 97

SP - 1825

EP - 1827

JO - Archives of Toxicology

JF - Archives of Toxicology

SN - 0340-5761

IS - 6

ER -

Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities

Bibliographical note

Keywords

Access to Document

Other files and links

FWOSB134: Development and application of a human stem cell-derived, etiology-based anti-MAFLD drug discovery platform targeting the thyroid hormone receptor axis

Colgate-Palmolive postdoctoral fellowship award in in vitro toxicology

Cite this

Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities

Bibliographical note

Keywords

Access to Document

Other files and links

Projects

FWOSB134: Development and application of a human stem cell-derived, etiology-based anti-MAFLD drug discovery platform targeting the thyroid hormone receptor axis

Prizes

Colgate-Palmolive postdoctoral fellowship award in in vitro toxicology

Cite this